Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis-Reference-Cited by-同舟云学术

Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis

Published:2014-10-28 Issue:1 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

van der Geest Patrick J,Dieters Erik I,Rijnders Bart,Groeneveld Johan AB

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/s12879-014-0575-3/fulltext.html

Reference25 articles.

1. El-Ebiary M, Torres A, Fabregas N, Puig de la Bellacasan J, Gonzalez J, Ramirez J, del Bano D, Hernandez C, Jimenez de Anta MT: Significance of the isolation of candida species from the respiratory samples in critically ill, non-neutropenic patients: an immediate post- mortem histologic study. Am J Respir Crit Care Med. 1997, 156: 583-590. 10.1164/ajrccm.156.2.9612023.

2. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J: The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest. 1998, 14: 146-149. 10.1378/chest.114.1.146.

3. Charles PE, Dalle F, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B: Candida spp. colonization significance in critically ill medical patients; a prospective study. Intensive Care Med. 2005, 31: 393-400. 10.1007/s00134-005-2571-y.

4. Eggimann P, Calandra T, Fluckiger U, Bille J, Garbino J, Glauser MP, Marchetti O, Ruef C, Tauber M, Pittet D: Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists. Intensive Care Med. 2005, 31: 1514-1521. 10.1007/s00134-005-2809-8.

5. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA: A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006, 34: 730-737. 10.1097/01.CCM.0000202208.37364.7D.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia;Microbial Pathogenesis;2022-05

2. Conventional Antifungals for Invasive Infections Delivered by Unconventional Methods; Aerosols, Irrigants, Directed Injections and Impregnated Cement;Journal of Fungi;2022-02-21

3. Five-Year Surveillance of Central Line Associated Bloodstream Infection in an Intensive Care Unit Population—A Retrospective Analysis;Advances in Infectious Diseases;2022

4. Candida Colonization in the Respiratory Tract: What Is the Significance?;Frontiers in Medicine;2021-02-04

5. Antifungal effects of PC945, a novel inhaled triazole, on Candida albicans-infected immunocompromised mice;2020-07-27